{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:1674",
      "entity_text" : "MC",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02338",
      "entity_text" : "omalizumab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The mechanism by which omalizumab decreases the release of MC mediators in asthma and in spontaneous chronic urticaria appears to be related with its ability to block the binding of circulating IgE antibodies to FcepsilonRI receptors on the surface of MCs and basophils resulting into a decrease on receptor expression, or by interfering with the release of MC mediator.",
  "reading_complete" : "2020-08-04T11:13:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:10:34Z",
  "trigger" : "decreases",
  "evidence" : [ "omalizumab decreases the release of MC" ],
  "pmc_id" : "5502410",
  "score" : 0
}